Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2004 / Cilt: 18 - Sayı: 3

The effect of diabetic patient serum on rat Schwann cell viability in vitro

Diabetik hasta serumunun sıçanda Schwann hücre canlılığı üzerine in vitro etkisi

Pages
221–227
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that diabetic patient serum did not induce significantly cell death in SC cultures as compared with control cultures.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Schwann cells (SCs) are gkal cells which are responsible for the myelin production and supporting nerve function in peripheral nerve system.
📊
Key Findings & Data:To evaluate whether diabetic patient serum has similar effect on SC viability, the effect of patient serum on SC viabikty has been determined in SC cultures, Material and method: In the present study, diabetic patient serum and normal control serum were added to SC cultures that were prepared from rat sciatic nerve. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was used to evaluate cell viability.
💡
Conclusion & Impact:Results: It was found that diabetic patient serum did not induce significantly cell death in SC cultures as compared with control cultures.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Schwann hücreleri · Hücre sağkalımı · Diabetes mellitus

Abstract

Schwann cells (SCs) are gkal cells which are responsible for the myelin production and supporting nerve function in peripheral nerve system. SC loss or in¬jury occur in diabetic neuropathy. Recent studies have reported that diabetic patients serum leads cell death in dorsal root ganglion neuron culture. To evaluate whether diabetic patient serum has similar effect on SC viability, the effect of patient serum on SC viabikty has been determined in SC cultures, Material and method: In the present study, diabetic patient serum and normal control serum were added to SC cultures that were prepared from rat sciatic nerve. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was used to evaluate cell viability. Results: It was found that diabetic patient serum did not induce significantly cell death in SC cultures as compared with control cultures. Conclusion: The results of the present study show that diabetic patient serum does not result significant cytotoxicity in rat SC cultures.

Özet

Amaç: Schwann hücresi (SH) periferik sinirlerde aksonların miyelin kilifinın yapiminı saglayarak sinir fonksiyonunu destekleyen glial hücredir. Diabetik nöropatide SH kaybı ya da hasarı gözlenmektedir. Daha önceki çalismalar diabetik hasta serumunun arka kok ganglion noron kültüründe hücre ölümüne yol actigiru göstermiştir. Diabetik hasta serumunun SH üzerine benzer bir etkisinin olup olmadigini arastirmak amaciyla bu çalışmada diabetik hasta serumunun in vitro sican SH cankkgi uzerine etkisi degerlendiriknistir. Gereç ve yöntem: Bu calışmada sican siyatik sinirinden hazirlanan SH kültürlerine diabetik hasta serumu ve normal kontrol serumu lsiyla inaktivasyon sonrasi degisik oranlarda eklendi. Hücre canlılıginin değerlendirilmesinde 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) testi kullanildi. Bulgular: Normoglisemik kontrol kiiltiirleriyle karsilastirildiginda diabetik hasta serumu eklenen SH kültürlerinde hücre canlılıginin istatistiksel olarak anlamli fark gostermedigi saptandi. Sonuc;: Bu sonuclar lsiyla inaktive edilmis diabetik hasta serumunun sican SH kültürleri üzerine anlamli bir toksisitesinin olmadigini gostermektedir.

🔖

Cite This Article

ÖZYURT, D., GENÇ, K. K., GENÇ, Ş., TEKMEN, I., SÖNMEZ, Ü., ALTUNGÖZ, O., ÇÖMLEKÇİ, A. (2004). The effect of diabetic patient serum on rat Schwann cell viability in vitro. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 18 - Sayı: 3, 221–227. https://ajindex.com/articles/210104

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA. Complications, neuropathy, pathogenetic considerations. Diabetes Care 1992;15:1902-1925
  2. Tomlinson DR. Future prevention and treatment of diabetic neuropathy. Diabetes Metab 1998;24:79-83
  3. Pittenger GL, Liu D, Vinik AI. The toxic effects of serum from patients with type I diabetes mellitus on mouse neuroblastoma cells: a new mechanism for development of diabetic autonomic neuropathy. Diabet Med 1993;10:925-932
  4. Vinik AI, Erbas T, Stansberry KB, Pittenger GL. Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 2001; 109: 451-473
  5. Pittenger GL, Liu D, Vinik AI. The neuronal toxic factor in serum of type 1 diabetic patients is a complement- fixing autoantibody. Diabet Med 1995; 12: 380- 386
  6. Pittenger GL, Liu D, Vinik AI. The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated. J Neuroimmunol 1997; 76: 153-160
  7. Srinivasan S, Stevens MJ, Sheng H, Hall KE, Wiley JW. Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calciumdependent apoptosis in cultured neuronal cells. J Clin Invest 1998; 102: 1454-1462
  8. Mirsky R, Jessen KR. The neurobiology of Schwann cells. Brain Pathol 1999; 9: 293-311
  9. Mirsky R, Jessen KR, Brennan A et al. Schwann cells as regulators of nerve development. J Physiol Paris 2002; 96:17-24
  10. Morgan L. Schwann cell culture. In ‘Neural Cell Culture. A Practical Approach’ J. Cohen, G.P. Wilkin eds. Oxford: Oxford University Press, 1995; 221-239
  11. Delaney CL, Russell JW, Cheng HL, Feldman EL. Insulin-like growth factor-I and over-expression of BclxL prevent glucose-mediated apoptosis in Schwann cells. J Neuropathol Exp Neurol 2001; 60: 147-160
  12. Myers SF. Myelin-sheat abnormalities in the vestibular nerves of chronically diabetic rats. Otolaryngol Head Neck Surg 1998;119:432-438
  13. Mizisin AP, Shelton GD, Wagner S, Rusbridge C, Powell HC. Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy. Acta Neuropathol 1998;95:171-174
  14. Mizisin AP, Shelton GD, Burgers ML, Powell HC, Cuddon PA. Neurological complications associated with spontaneously occurring feline diabetes mellitus. J Neuropathol Exp Neurol 2002;61: 872-884
  15. Mizisin AP. Comparative neuropathology and diabetic autonomic neuropathy. Am J Pathol 2003; 163: 1703- 1706
  16. Jaffey PB, Gelma